These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 19581181

  • 1. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G.
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [Abstract] [Full Text] [Related]

  • 2. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Malignancy after renal transplantation.
    Zeier M, Hartschuh W, Wiesel M, Lehnert T, Ritz E.
    Am J Kidney Dis; 2002 Jan 10; 39(1):E5. PubMed ID: 11774131
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urological malignancy after renal transplantation.
    Besarani D, Cranston D.
    BJU Int; 2007 Sep 10; 100(3):502-5. PubMed ID: 17669141
    [Abstract] [Full Text] [Related]

  • 7. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H.
    J Heart Lung Transplant; 2007 Jun 10; 26(6):557-64. PubMed ID: 17543777
    [Abstract] [Full Text] [Related]

  • 8. [Cancer in organ transplanted patients].
    Pfeffer PF.
    Tidsskr Nor Laegeforen; 1999 Oct 20; 119(25):3792-4. PubMed ID: 10574060
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Malignant tumors following renal transplantation].
    Végso G, Járay J.
    Orv Hetil; 2007 Nov 11; 148(45):2115-23. PubMed ID: 17984022
    [Abstract] [Full Text] [Related]

  • 13. Gynecological issues after organ transplantation.
    Kaminski P, Bobrowska K, Pietrzak B, Bablok L, Wielgos M.
    Neuro Endocrinol Lett; 2008 Dec 11; 29(6):852-6. PubMed ID: 19112398
    [Abstract] [Full Text] [Related]

  • 14. Study on eight patients with malignant tumors after renal transplantation.
    Marubayashi S, Tashiro H, Watanabe H, Fudaba Y, Hayamizu K, Ohdan H, Okimasa S, Katayama K, Itamoto T, Haruta N, Okajima M, Kataoka T, Sugino K, Yahata H, Ishikawa T, Fukuda Y, Dohi K, Asahara T.
    Hiroshima J Med Sci; 2000 Jun 11; 49(2):117-20. PubMed ID: 10920578
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive therapy does not prevent the occurrence of immunoglobulin E-mediated allergies in children and adolescents with organ transplants.
    Dehlink E, Gruber S, Eiwegger T, Gruber D, Mueller T, Huber WD, Klepetko W, Rumpold H, Urbanek R, Szépfalusi Z.
    Pediatrics; 2006 Sep 11; 118(3):e764-70. PubMed ID: 16950967
    [Abstract] [Full Text] [Related]

  • 16. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
    Kuypers DR, Le Meur Y, Cantarovich M, Tredger MJ, Tett SE, Cattaneo D, Tönshoff B, Holt DW, Chapman J, Gelder Tv, Transplantation Society (TTS) Consensus Group on TDM of MPA.
    Clin J Am Soc Nephrol; 2010 Feb 11; 5(2):341-58. PubMed ID: 20056756
    [Abstract] [Full Text] [Related]

  • 17. Toward the definition of immunosuppressive regimens with antitumor activity.
    Casadio F, Croci S, D'Errico Grigioni A, Corti B, Grigioni WF, Landuzzi L, Lollini PL.
    Transplant Proc; 2005 Jun 11; 37(5):2144-7. PubMed ID: 15964362
    [Abstract] [Full Text] [Related]

  • 18. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis.
    Arness T, Pedersen R, Dierkhising R, Kremers W, Patel R.
    Transpl Infect Dis; 2008 Jul 11; 10(4):260-8. PubMed ID: 18086277
    [Abstract] [Full Text] [Related]

  • 19. Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center.
    Domingo-Domènech E, de Sanjosé S, González-Barca E, Romagosa V, Domingo-Clarós A, Gil-Vernet S, Figueras J, Manito N, Otón B, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2001 Jul 11; 86(7):715-21. PubMed ID: 11454526
    [Abstract] [Full Text] [Related]

  • 20. Immunosuppression in renal transplantation: some aspects for the modern era.
    Chadban S, Morris R, Hirsch HH, Bunnapradist S, Arns W, Budde K.
    Transplant Rev (Orlando); 2008 Oct 11; 22(4):241-51. PubMed ID: 18657962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.